"Enterogenous" cyanosis.
D000328:Adult; D000700:Analgesics / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects*; D001391:Azo Compounds / Q000009:adverse effects*; D003490:Cyanosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008382:Marfan Syndrome / Q000188:drug therapy; D010621:Phenazopyridine / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects*; D013436:Sulfhemoglobinemia / Q000139:chemically induced / Q000150:complications*; D013444:Sulfisoxazole / Q000009:adverse effects*
D000700:Analgesics; D000779:Anesthetics, Local; D001391:Azo Compounds; D011725:Pyridines; D013444:Sulfisoxazole; D010621:Phenazopyridine